ArticleArchives of microbiology2026
Construction and characterization of the first Arcobacter butzleri - Escherichia coli shuttle vector.
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study addresses a key limitation in the genetic characterisation of Arcobacter butzleri, an emerging food- and waterborne pathogen associated with gastrointestinal and systemic infections in humans and animals. Despite the identification of numerous putative virulence genes, functional validation has been hindered by the absence of suitable complementation tools. Here, we report the development and characterisation of the first shuttle vector capable of replication in both Escherichia coli and A. butzleri. A total of 117 A. butzleri isolates were screened for plasmids, leading to the identification and sequencing of a novel cryptic plasmid, pABRW13 (3,402 bp), from a waterborne strain. This plasmid revealed four open reading frames, including a putative replication-associated gene. These elements were incorporated into a novel shuttle vector, pIMM24 (7,425 bp), together with a tetracycline resistance cassette (tetO), using the pBluescript KS derivative pMW2 vector as backbone. The resulting construct successfully replicated in both hosts, exhibited stable maintenance in E. coli and moderate stability in A. butzleri, and conferred increased tetracycline resistance. Functional validation was achieved by complementation of a fliS knockout mutant, restoring motility to near wild-type levels. Overall, pIMM24 represents a significant advancement in the genetic toolkit available for A. butzleri, enabling gene complementation studies and facilitating deeper insights into its physiology and pathogenic mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.